Alphanosos uses its own artificial Intelligence algorithms to discover, develop and sell active ingredients and products based on mixes of extracts from non-pharmaceutical ingredients, in particular botanic. These active mixes, some already patented in 15 countries for their antimicrobial properties, are aimed at the animal hygiene, dermocosmetic, food preservation and cosmetic sectors, and in the long term functional foods and to treat illnesses. The company began its R&D in 2015 and is today a commercial business which mainly works via distributors for its products and via industrial and commercial groups for the awarding of new R&D projects and licences. Alphanosos currently uses its patented active ingredients in its products aimed at both animals and humans targeting specific needs, such as eczema and pyodermititis. The AI platform is used in partnerships to discover new active ingredients and optimise formulae with the aim of generating intellectual property on strong biological properties, in particular antibacterial and anti-fungal, as well as antiviral and various cellular properties of interest for use in cosmetics like optimising bio-productions.
